Intraoperative Radiotherapy for Breast Cancer in Elderly Women

被引:4
|
作者
Guillerm, S. Ophie [1 ,2 ]
Bourstyn, Edwige [1 ,2 ]
Itti, Ramona [1 ,2 ]
Cahen-Doidy, Laurence [1 ,2 ]
Quero, Laurent [1 ,2 ]
Labidi, Mouna [1 ,2 ]
Marchand, Eva [1 ,2 ]
Lorphelin, Henri [1 ,2 ]
Giacchetti, Sylvie [1 ,2 ]
Cuvier, Caroline [1 ,2 ]
Espie, Marc [1 ,2 ]
Teixeira, Luis [1 ,2 ]
Hennequin, Christophe [1 ,2 ]
机构
[1] St Louis Hosp, Radiat Oncol Dept, Paris, France
[2] St Louis Hosp, Breast Canc Unit, Paris, France
关键词
Breast cancer; Intraoperative radiotherapy; Local control; Cosmetic result; LUMPECTOMY PLUS TAMOXIFEN; KILOVOLTAGE X-RAYS; CONSENSUS STATEMENT; CONSERVING SURGERY; RADIATION-THERAPY; IRRADIATION; RECURRENCE; OLDER; METAANALYSIS; MORTALITY;
D O I
10.1016/j.clbc.2021.05.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Intraoperative radiotherapy (IORT) with low-energy photons was delivered to 191 women >65 years of age. Only 8 patients had postoperative external beam radiotherapy. 5-year local relapse rate was 1.7%. Postoperative complications were rare, without delay in wound healing, even in older women. Cosmetic result was good or excellent in >90% of the patients. Purpose: To evaluate outcomes and postoperative toxicities after intraoperative radiotherapy (IORT) in elderly women. Population: Women older than 65 years, with infiltrating ductal breast cancer <= 3 cm, expressing estrogen receptor (ER+) without Her2 overexpression, and with negative axillary nodes. Treatment: Treatment consisted of partial mastectomy with a sentinel lymph node biopsy (SLNB) procedure; in case of positive SLNB, IORT was cancelled. IORT consisted in a total dose of 20 Gy in 1 fraction delivered at the surface of the applicator with the Intrabeam (R) technique. Results: IORT was planned to be administered to a total of 225 patients but was cancelled for 34 patients during surgery. Thus 191 patients were analyzed; mean age was 76 years, with 57 patients (30%) >80 years. Despite inclusion criteria, 15 had lobular carcinoma and 7 were triple negative. With a median follow-up of 40 months, we observed only 1 local recurrence, located in the skin over the initial tumor. The 5-year local relapse rate was 1.7%. A wound healing delay ( >15 days) was observed in 21 patients (11%). Sixty-six patients (35%) had postoperative complications, mainly grade 2, resolving within a few days. Two patients needed surgical drainage for local abscesses. Long-term ( >1 year) cosmetic outcome was evaluated in 120 patients and was judged excellent or good in 102 (91%). Conclusion: IORT can be safely given to elderly women, with a good local control rate and without major toxicities. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:E109 / E113
页数:5
相关论文
共 50 条
  • [21] Focus on the Actual Clinical Target Volume Irradiated with Intraoperative Radiotherapy for Breast Cancer
    Guenzi, Marina
    Fozza, Alessandra
    Blandino, Gladys
    Timon, Giorgia
    Belgioia, Liliana
    Vidano, Giulia
    Cavagnetto, Francesca
    Gusinu, Marco
    Agostinelli, Stefano
    Garelli, Stefania
    Zeverino, Michele
    Taccini, Gianni
    Corvo, Renzo
    ANTICANCER RESEARCH, 2012, 32 (11) : 4945 - 4950
  • [22] Intraoperative Radiotherapy of the Breast for Early-Stage Breast Cancer: Ready for Primetime
    Holmes, Dennis R.
    BREAST JOURNAL, 2015, 21 (02) : 181 - 184
  • [23] A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer
    Sperk, Elena
    Astor, Daniela
    Keller, Anke
    Welzel, Grit
    Gerhardt, Axel
    Tuschy, Benjamin
    Sutterlin, Marc
    Wenz, Frederik
    RADIATION ONCOLOGY, 2014, 9
  • [24] Update on intraoperative radiotherapy for early-stage breast cancer
    Feng, Kexin
    Meng, Xiangzhi
    Liu, Jiaqi
    Xing, Zeyu
    Zhang, Menglu
    Wang, Xin
    Feng, Qinfu
    Wang, Xiang
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (07): : 2032 - 2042
  • [25] Intraoperative radiotherapy (IORT) as boost in breast cancer
    Sedlmayer, Felix
    Reitsamer, Roland
    Wenz, Frederik
    Sperk, Elena
    Fussl, Christoph
    Kaiser, Julia
    Ziegler, Ingrid
    Zehentmayr, Franz
    Deutschmann, Heinz
    Kopp, Peter
    Fastner, Gerd
    RADIATION ONCOLOGY, 2017, 12 : 23
  • [26] Effect of adjuvant radiotherapy in elderly patients with breast cancer
    Stueber, Tanja Nadine
    Diessner, Joachim
    Bartmann, Catharina
    Leinert, Elena
    Janni, Wolfgang
    Herr, Daniel
    Kreienberg, Rolf
    Woeckel, Achim
    Wischnewsky, Manfred
    PLOS ONE, 2020, 15 (05):
  • [27] Outcomes and complications of intraoperative radiotherapy versus external beam radiotherapy for early breast cancer
    Zangouri, Vahid
    Roshanshad, Amirhossein
    Ranjbar, Aliyeh
    Izadi, Mahsa
    Rajaeifar, Sara
    Goodarzi, Ali
    Nasrollahi, Hamid
    CANCER REPORTS, 2024, 7 (02)
  • [28] Adjuvant radiotherapy in postmenopausal women with early-stage ER-positive breast cancer: A systematic review and meta-analysis
    Taha, Amira M.
    Kamel, Hanaa Abdelmoneim
    Khlidj, Yehya
    Salem, Dalal Salama
    Saed, Sara Adel Abdelkader
    Abouelmagd, Khaled
    Nguyen, Dang
    Shash, Emad
    Chapagain, Sanskriti
    Kassem, Loay
    MEDICINE, 2025, 104 (08) : e41632
  • [29] Phase II study on the use of intraoperative radiotherapy in early breast cancer
    Merdad, Adnan A.
    Bahadur, Yasir A.
    Fawzy, Ehab E.
    Hassouna, Ashraf H.
    Eltaher, Maha M.
    Alghaithy, Zuhoor K.
    Al-Thoubaity, Fatma K.
    Constantinescu, Camelia T.
    SAUDI MEDICAL JOURNAL, 2013, 34 (11) : 1133 - 1138
  • [30] INTRAOPERATIVE RADIOTHERAPY IN EARLY-STAGE BREAST CANCER: RESULTS OF THE MONTPELLIER PHASE II TRIAL
    Lemanski, Claire
    Azria, David
    Gourgon-Bourgade, Sophie
    Gutowski, Marian
    Rouanet, Phillippe
    Saint-Aubert, Bernard
    Ailleres, Norbert
    Fenoglietto, Pascal
    Dubois, Jean-Bernard
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 76 (03): : 698 - 703